由成年转基因山羊体细胞而来的克隆山羊

在已经获得的乳腺特异性表达人促红细胞生成素 (rhEPO)成年转基因山羊 (Caprahircus)的基础上 ,取其耳尖成纤维细胞和卵巢颗粒细胞 ,进行体外传代培养 ,然后将这种培养的转基因山羊的体细胞移入去核的处于第Ⅱ次减数分裂中期的卵母细胞中 ,并进行电融合 ,构建重构胚胎 ,重构胚胎在体内培养 6d ,再将发育至囊胚或桑椹胚的重构胚胎移入同步情期的寄母羊子宫内。结果 ,有 2只寄母羊妊娠并最终产下 2只成活的克隆山羊。她们分别来自同一成年母羊的耳尖成纤维细胞和卵巢颗粒细胞。克隆羊经PCR RFLP图谱分析显示 :以克隆羊组织DNA为模板的PCR产物与相应的提供体细胞的基因羊的PCR产物的酶切图谱完全一致 ;并且经PCR对外源hEPO基因检测表明 2只克隆山羊均携带hEPO外源基因。由此证明获得了转基因成年体细胞的克隆山羊     

转基因克隆奶山羊大量生产重组人的抗凝血酶III蛋白质(rhATIII)

利用转基因克隆奶山羊乳腺生物反应器大量生产重组人的抗凝血酶III(rhATIII)蛋白质。其中包括: 筛选出人的抗凝血酶Ⅲ蛋白基因的cDNA序列; 利用山羊的b－酪蛋白基因的启动区, 终止信号和Enterokinase蛋白酶酶切DNA序列, 构建在乳腺中特异表达rhATⅢ的表达载体。同时在转基因载体的末端连接一个新酶素筛选基因(Neomycin)。再以细胞转染、G418筛选和体细胞核移植(动物克隆)等过程, 最后获得含有人的抗凝血酶Ⅲ基因的转基因克隆奶山羊。我们共获得了5个原代转基因公羊。第一只克隆羊在出生后78 d死亡, 解剖表明: 羊的肺部和肾脏等器官有异常。其它克隆公羊经过与崂山种母羊交配, 得到转基因后代, 其中两个原代转基因羊的后代母羊已成熟、所获得的奶经蛋白质电泳证明: 转基因克隆羊后代奶中含有约60 kD大小的rhATⅢ糖蛋白; 经Elisa检测表明: 在奶中含有大量活性的rhATⅢ, 在来源于两个不同克隆公羊的后代母羊奶中的rhATⅢ含量分别为0.4 mg/L和3 g/L。此研究证明: 转基因奶山羊可以大量地生产具有很高活性的rhATⅢ。用这种方法生产的rhATⅢ通过蛋白质提纯, 制成注射针剂, 将可用于人的抗凝血酶III缺乏症的治疗、预防血栓和重大手术过程中的止血的作用等。     

转基因克隆奶山羊大量生产重组人的抗凝血酶III蛋白质(rhATIII)

利用转基因克隆奶山羊乳腺生物反应器大量生产重组人的抗凝血酶III(rhATIII)蛋白质。其中包括: 筛选出人的抗凝血酶Ⅲ蛋白基因的cDNA序列; 利用山羊的b－酪蛋白基因的启动区, 终止信号和Enterokinase蛋白酶酶切DNA序列, 构建在乳腺中特异表达rhATⅢ的表达载体。同时在转基因载体的末端连接一个新酶素筛选基因(Neomycin)。再以细胞转染、G418筛选和体细胞核移植(动物克隆)等过程, 最后获得含有人的抗凝血酶Ⅲ基因的转基因克隆奶山羊。我们共获得了5个原代转基因公羊。第一只克隆羊在出生后78 d死亡, 解剖表明: 羊的肺部和肾脏等器官有异常。其它克隆公羊经过与崂山种母羊交配, 得到转基因后代, 其中两个原代转基因羊的后代母羊已成熟、所获得的奶经蛋白质电泳证明: 转基因克隆羊后代奶中含有约60 kD大小的rhATⅢ糖蛋白; 经Elisa检测表明: 在奶中含有大量活性的rhATⅢ, 在来源于两个不同克隆公羊的后代母羊奶中的rhATⅢ含量分别为0.4 mg/L和3 g/L。此研究证明: 转基因奶山羊可以大量地生产具有很高活性的rhATⅢ。用这种方法生产的rhATⅢ通过蛋白质提纯, 制成注射针剂, 将可用于人的抗凝血酶III缺乏症的治疗、预防血栓和重大手术过程中的止血的作用等。     

利用体细胞核移植技术制作人胰岛素原转基因牛 （英文）

通过体细胞核移植技术制作了人胰岛素原转基因牛。在CMV启动子指导下以内部核糖体进入位点序列(IRES)连接的新霉素抗性基因和绿色荧光蛋白基因组成了双重标记基因的筛选系统,用于转基因细胞的富集以及细胞和植入前胚胎的筛选。转基因通过电穿孔的方法(900V/cm,5ms)转入体外培养的牛胎儿成纤维细胞,基因转染细胞在添加G418 (800μg/mL)的培养基中培养10天以富集转基因细胞。选择表达绿色荧光蛋白的转基因细胞作为核供体进行体细胞核移植,重构胚经体外培养至囊胚阶段,选择表达绿色荧光蛋白的囊胚进行胚胎移植。为比较基因转染以及供体细胞所处周期对转基因细胞核移植胚胎发育的影响,用作核移植供体的转基因细胞或非转基因细胞先饥饿培养2—4天(0.5 ?S) ,然后恢复培养(10?S) 10 h使细胞同步化于G1期,以正常培养的细胞作为对照进行核移植。结果表明,转基因细胞作为核供体得到的核移植胚胎的体外囊胚发育率低于以非转基因细胞为核供体的对照组(23.2% VS 35.2 %,P<0.05) ;转基因细胞周期同步化处理与否对其克隆胚囊胚发育率无显著影响(23.2% VS 18.9 %,P>0.05)。胚胎移植后2个月直肠检查发现7头受体牛(每头移植2—4枚胚胎)中有一头妊娠,并最终发育足月产下一头小牛。聚合酶链反应(PCR)检测和DNA测序分析表明其为转人胰岛素原基因的转基因克隆牛。     

整合人lactoferrin基因的山羊体细胞支持核移植克隆胚的体外发育

克隆了人lactoferrin基因和山羊[[beta]]-casein基因5′端调控区, 构建了人lactoferrin的乳腺表达载体, 并将该载体利用脂质体介导转染了奶山羊胎儿成纤维细胞, 获得了稳定整合人lactoferrin基因的转基因体细胞克隆17个, 其中PCR和Southern Blot检测阳性的细胞克隆14个, 阳性率82.4%。以转基因体细胞为供体细胞进行了核移植, 获得了能够体外发育的山羊转基因克隆胚胎, 体内成熟卵母细胞来源的核移植囊胚率为64.8%, 体外成熟卵母细胞来源的核移植囊胚率为51.7%, 证明了山羊转基因体细胞能够支持克隆胚的进一步发育。     

牛-牛及山羊-牛克隆胚胎体外培养条件的优化

通过胞质内注射法将牛和山羊胎儿耳朵成纤维细胞分别注入去核牛卵母细胞中构建同种胚胎和异种胚胎。采用mCR2aa和mSOF分别培养, 然后在mSOF中按不同培养时间添加8mg/mL BSA或者10%FBS,培养前3d和培养3d后添加的补充物质及次序为：(1)BSA+FBS;(2)BSA+BSA; (3)FBS+BSA;(4)FBS+FBS。根据培养胚胎的卵裂率、8/16-cell发育率、囊胚发育率及囊胚细胞数筛选出最好的培养方法。结果：(1)mSOF中培养同种胚胎和异种胚胎的卵裂率,8/16-cell发育率以及囊胚发育率均明显高于在mCR2aa中的培养结果（P<0.05 ）。(2)添加BSA+FBS组的mSOF培养胚胎的卵裂率、8/16-cell发育率、囊胚发育率和囊胚细胞数同种依次为79.8%±7.1%、49.7%±3.5%、21.5%±1.8%和115.2±4.3,异种依次为40.1%±6.3%、29.2%±2.0%、13.4%±2.1%和100.1±3.0,均明显高于其他培养组（P<0.05）。结论：山羊-牛异种克隆胚胎可以用优化的牛胚胎培养体系进行培养。同种胚胎和异种胚胎的最佳培养方法均为前3d用mSOF+BSA培养液,3d后用mSOF+FBS培养液。     

牛-牛及山羊-牛克隆胚胎体外培养条件的优化

通过胞质内注射法将牛和山羊胎儿耳朵成纤维细胞分别注入去核牛卵母细胞中构建同种胚胎和异种胚胎。采用mCR2aa和mSOF分别培养,然后在mSOF中按不同培养时间添加8mg/mLBSA或者10?S,培养前3d和培养3d后添加的补充物质及次序为:(1)BSA FBS;(2)BSA BSA;(3)FBS BSA;(4)FBS FBS。根据培养胚胎的卵裂率、8/16-cell发育率、囊胚发育率及囊胚细胞数筛选出最好的培养方法。结果:(1)mSOF中培养同种胚胎和异种胚胎的卵裂率,8/16-cell发育率以及囊胚发育率均明显高于在mCR2aa中的培养结果(P<0.05)。(2)添加BSA FBS组的mSOF培养胚胎的卵裂率、8/16-cell发育率、囊胚发育率和囊胚细胞数同种依次为79.8%±7.1%、49.7%±3.5%、21.5%±1.8%和115.2±4.3,异种依次为40.1%±6.3%、29.2%±2.0%、13.4%±2.1%和100.1±3.0,均明显高于其他培养组(P<0.05)。结论:山羊-牛异种克隆胚胎可以用优化的牛胚胎培养体系进行培养。同种胚胎和异种胚胎的最佳培养方法均为前3d用mSOF BSA培养液,3d后用mSOF FBS培养液。     

Generation of cloned goats (Capra hircus) from transfected foetal fibroblast cells, the effect of donor cell cycle.

The neomycin-resistant gene (neo(r)) is probably the most commonly used selectable marker gene in gene targeting and gene transfection research. In this study, the neo(r) gene construct was introduced into in vitro cultured goat foetal fibroblast cells (IV-5), and the cells were selected with 900 microg/ml G418. The G418-resistant colonies were analysed by neo-specific PCR, karyotyping and anti-intermediate filament proteins antibody (anti-vimentin) staining. Cell cycle analysis of the neo(r) positive foetal fibroblast cell colony (IV-5.1) cultured in a variety of cell cycle-arresting medium indicated that 74.2% of cells cultured in serum-deprived medium for 3 days and 71.7% of cells grown to confluence were at G0/G1 stage of cell cycle, respectively, in comparison to 61.6% of cells in normal culture (cycling) medium. Nocodazole treatment for 17 hr in vitro culture could increase the number of cells at G2/M stage of cell cycle from 20.3% (in cycling medium) to 39.7%. In total, one early pregnancy was observed by B ultra-sound scanning in a surrogate transferred with cloned embryos from IV-5.1 cells at M stage (cells were cultured in nocodazole medium). Seven cloned goats, including two that miscarried at a late stage, were derived from the IV-5.1 cell clone cultured in starved medium (G0). Indeed, one surrogate receiving three blastocysts reconstituted from the starved donor cells, gave birth to three live cloned goats, all of which are healthy and doing well. PCR, Southern blot and G418 resistance in vitro of fibroblast cells from cloned goats confirmed that all cloned goats are positive for neo(r) transgene. This study demonstrates that a foreign gene, such as the neo-resistant gene, can be introduced into goat foetal fibroblast cells, and that the resulting transgenic cells are capable of being cloned to produce 100% transgenic animals.     

Development of reconstituted embryos derived from transgenic embryonic stem cell nuclei

This study was carried out to transform embryonic stem (ES) cells and to produce the reconstituted embryos derived from transgenic ES cell nuclei. Then, in vitro/vivo developmental potency of transgenic ES cells were compared to that of control ES cells (non-transgenic ES cells) in the reconstituted embryos. Unfertilized B6D2F1 ooplasm at metaphase II (M II) and two kinds of ES cell lines, 129SV and transgenic (tg) 129SV transformed by EGFP gene, were used as nuclear recipients and nuclear donors, respectively. The M II chromosome-spindle complex was aspirated into the pipette with a minimal volume of ooplasm. After enucleation, the ES cell nuclei was injected into the enucleated ooplasm directly. Then, reconstituted embryos were activated in SrCl2, and they were cultured in HTF medium. There was no difference of developmental rate between reconstituted embryos derived from the control (non-transgenic) and the tg ES cells. From this result, we indicated that transgenic ES cells might not change the property of peculiarity of the ES cell by gene transfer. The expression of GFP gene in the embryos was observed by fluorescence microscope at the 4-cell and more stage. As comparison with development of the embryos derived from the control and tg ES cells, the difference of the development could not be confirmed between the two cell groups. When the reconstituted embryos derived from the control and tg ES cells were transferred into oviduct or uterus of pseudopregnant females, fetuses were observed 13.5 days post coitum. However, in all fetuses, developmental arrest and regression were seen 19.5 days post coitum.     

抗酶1基因转染对HeLa细胞增殖及细胞周期的抑制作用

研究抗酶(antizyme)1对人宫颈癌HeLa细胞增殖与细胞周期的影响,并分析抗酶1对细胞周期蛋白D1(cyclin D1)的表达影响.采用定点突变技术,将抗酶1的frameshift位点缺失,随后将突变基因重组至真核表达载体pEGFP-N1中,鉴定后转染HeLa细胞.通过MTT法检测细胞增殖变化,流式细胞术分析抗酶1对细胞周期的影响.RT-PCR和Western印迹检测抗酶1转染对细胞周期蛋白 D1基因表达的影响.酶切结果显示,抗酶1突变基因成功克隆至pEGFP-N1中.成功转染HeLa细胞后,检测结果显示,抗酶1能够减慢HeLa细胞增殖速度,并使细胞停滞于G₀/G₁期,细胞周期蛋白D1基因的表达同时受到抑制.实验说明,抗酶1基因能够抑制HeLa细胞增殖,通过降低细胞周期蛋白D1的表达阻滞细胞周期.     

INHIBITION OF CELL DIVISION BUT NOT NUCLEAR DIVISION BY 1- O -OCTADECYL-2- O -METHYL- Sn -GLYCERO-3-PHOSPHOCHOLINE

1- O -Octadecyl-2- O -methyl-glycero-3-phosphocholine (ET-18-OCH₃) selectively inhibits the growth of cancer cells. Here we show that in some cell types ET-18-OCH₃and liposome-associated ET-18-OCH₃inhibit cell division without concurrent inhibition of nuclear division, leading to multinucleate cell formation, and cell death through apoptosis. Cell cycle analysis revealed that ET-18-OCH₃-treated U-937 cells continued to move through the cell cycle, but many cells were not able to divide and instead accumulated as tetraploid cells or octaploid cells in the G0/G1 phase of the cell cycle. Inhibition of cytokinesis has been shown to be paralleled by activation of U-937 cells, including upregulation of some cell-surface markers, acquisition of phagocytic activity, and secretion of tumor necrosis factor (TNF)-α (Pushkareva et al., 2000). Furthermore, treatment of cells with ET-18-OCH₃results in the accumulation of apoptotic cells in time- and dose-dependent manner. It is possible that inhibition of cytokinesis may be related to cytoskeletal effects.     

Piglets produced from cloned blastocysts cultured in vitro with GM‐CSF

In general, pig embryos established by somatic cell nuclear transfer (SCNT) are transferred at the one‐cell stage because of suboptimal embryo culture conditions. Improvements in embryo culture can increase the practical application of late embryo transfer. The goal of this study was to evaluate embryos cultured with granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) in vitro, and to track the in vivo developmental competency of SCNT‐derived blastocysts from these GM‐CSF embryos. The receptor for GM‐CSF was up‐regulated in in vitro‐produced embryos when compared to in vivo‐produced cohorts, but the level decreased when GM‐CSF was present. In vitro fertilized (IVF) embryos, supplemented with GM‐CSF (2 or 10 ng/ml), showed a higher frequency of development to the blastocyst stage compared to controls. The total cell numbers of the blastocysts also increased with supplementation of GM‐CSF. Molecular analysis demonstrates that IVF‐derived blastocysts cultured with GM‐CSF exhibit less apoptotic activity. Similarly, an increase in development to the blastocyst stage and an increase in the average total‐cell number in the blastocysts were observed when SCNT‐derived embryos were cultured with either concentration of GM‐CSF (2 or 10 ng/ml). When SCNT‐derived embryos, cultured with 10 ng/ml GM‐CSF, were transferred into six surrogates at Day 6, five of the surrogates became pregnant and delivered healthy piglets. Our findings suggest that supplementation of GM‐CSF can provide better culture conditions for IVF‐ and SCNT‐derived embryos, and pig SCNT‐derived embryos cultured with GM‐CSF in vitro can successfully produce piglets when transferred into surrogates at the blastocyst stage. Thus, it may be practical to begin performing SCNT‐derived embryo transfer at the blastocyst stage. Mol. Reprod. Dev. © 2013 Wiley Periodicals, Inc.     

GABA Analogues Derived from 4-Aminocyclopent-1-enecarboxylic Acid

The incorporation of extra binding groups onto known ligands is a powerful tool for the development of more potent and selective agents at target sites such as the GABA receptors. In the present work we have attempted to build on the activity of the know potent GABA_A agonist 4-ACP-3-CA and its cis and trans saturated analogues CACP and TACP. We have investigated reactions to add thiol substituents to the α,β-unsaturated system of 4-ACP-3-CA. The reaction was successful with a limited number of thiols but gave products of mixed stereochemistry. The resultant thioether amino acids were screened for activity at human recombinant α₁β₂ γ_2L GABA_A receptors. The most interesting derivative was the benzylthioether which acted as an antagonist with an IC₅₀ of 42 μM for the inhibition of a GABA EC₅₀ dose (50 μM). This study has shown that GABA analogues derived by thiol addition to 4-aminocyclopent-1-enecarboxylic acid display interesting antagonist activity at the α₁β₂γ_2L GABA_A receptor. Special issue article in honour of Dr. Graham Johnston.     

猪克隆胚胎激活方法优化与转人溶菌酶基因克隆猪的生产

为了提高转基因克隆效率和获得转人溶菌酶基因克隆猪,研究了不同电激活参数和化学辅助激活方法对猪克隆胚胎和孤雌胚胎体外发育的影响.结果发现:电场强度会显著影响克隆胚胎的融合率和体外发育能力(P<0.05),电脉冲次数对克隆胚胎体外发育促进作用不显著(P>0.05),而相同电激活条件下克隆胚胎和孤雌胚胎的体外发育能力变化趋势不同;电激活后再利用放线菌酮+细胞松弛素B(CHX+CB)处理4 h能显著提高克隆胚胎的囊胚率(P<0.05),而用二甲基氨基嘌呤(6-DMAP)处理没有提高克隆胚胎囊胚率(P>0.05),但6-DMAP或CHX+CB处理均可显著提高孤雌胚胎的囊胚率(P<0.05).上述结果表明,最佳的孤雌激活条件并不一定是克隆胚胎的最佳激活条件.本研究中猪克隆胚胎的最佳激活方法为1.6 kV/cm、100μs、2次直流电脉冲间隔100μs,再辅以CHX+CB处理4 h.利用优化的激活条件成功获得了乳腺特异表达人溶菌酶的转基因猪,为猪转基因育种奠定了基础.     

1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte

The steroid hormone 1,25(OH)₂-vitamin D₃ [1,25D] has been shown to affect the growth and proliferation of primary cultures of ventricular myocytes isolated from neonatal rat hearts. The research presented here shows that the vitamin D receptor [VDR] is present in murine cardiac myocytes (HL-1 cells), and that 1,25D affects the growth, proliferation and morphology of these cells. In addition we show that 1,25D effects expression of ANP, myotrophin, and c-myc. Furthermore, 1,25D effects expression and localization of the VDR within the cell. Murine HL-1 cardiac myocytes were grown and treated with 1,25D in culture, and growth and morphology were assessed with microscopic analysis. Cells were counted and protein levels were evaluated through Western blot analysis. Subcellular localization of the VDR was determined using immunofluorescence and confocal microscopy. 1,25D was found to decrease proliferation and alter cellular morphology of the HL-1 cells. Treatment with 1,25D increased expression of myotrophin while decreasing expression of atrial natriuretic peptide [ANP] and c-myc. 1,25D treatment also increased expression and nuclear localization of the VDR in these cardiac myocytes. Thus 1,25D is an important hormone involved in modulating and maintaining heart cell structure and function.     

Simplified method for the determination of 25-hydroxy and 1α,25-dihydroxy metabolites of vitamins D2 and D3 in human plasma application to nutritional studies

A simplified method for the determination of 25-hydroxy and 1α,25-dihydroxy metabolites of vitamins D₂ and D₃ in human plasma was developed. Plasma samples were deproteinizated and applied to a Bond Elut C₁₈ OH cartridge to separate 25-hydroxyvitamin D (25-OH-D) and 1α-25-dihydroxyvitamin D [1,25(OH)₂D] fractions. The 25-OH-D fraction was purified by a Bond Elut C₁₈ cartridge and 25-OH-D₂ and 25-OH-D₃ were assayed by HPLC using a Zorbax SIL column. The 1,25(OH)₂D fraction obtained above was subsequently applied to HPLC using a Zorbax SIL column to separate 1,25(OH)₂D₂ and 1,25(OH)₂D₃ fractions which were determined by a radioreceptor assay (RRA) using calf thymus receptor. The method was applied to nutritional studies.     

转基因红鲤体细胞的核移植

以F4代转hGH基因红鲤体细胞（肾脏和尾鳍）及培养18代的F4代转hGH基因红鲤尾鳍细胞为核供体,泥鳅或黄河鲤成熟卵为受体,进行了核移植,以探讨外源F4代转基因鱼体外源基因的分布与存在形式,稳定性和克隆转基因鱼的可能性。F4代红鲁肾脏细胞核与泥鳅卵配合的核移植胚胎有12．4％发育到囊胚,0．33％发育到神经胚;F4代尾鳍细胞核移入泥鳅卵后的重组胚发育到囊胚,神经胚、肌节期和肌肉效应期的胚胎分别为24．5％、0．3％、0．2％和0．1％;对照卵无发育。F4代红鲤尾鳍培养细胞与黄河鲤卵子配合的重组胚胎有50．53％发育到囊胚,5．69％发育到原肠胚,0．53％发育到神经胚,0．4％发育到肌节期。说明由于同种细胞核与卵细胞的相容性高于异种核卵的相容性,早期发育率高;而由于培养细胞的异倍化,后期的发育率降低。用PCR技术对供体鱼不同个体及同一体不同组织外源基因检测,结果100％个体为阳性鱼,而且不同组织的阳性率也是100％,说明外源基因均匀分布在不同组织中。无论F4代转基因鱼的肾脏细胞、尾鳍细胞还是培养的尾鳍细胞作核移植供体,核移植胚胎中hGH基因的检出率为100％。说明F4代转基因红鲤个体不同细胞都存在hGH基因,而且经长期培养不会丢失。表明F4代转基因红鲤中的外源hGH基因已基本稳定,体细胞核移植可以作为获得同质化转基因鱼的有效手段,但核移植效率还很低。另外还讨论了核质的相容性、细胞周期的协调、染色体的变异等因素对核移植的影响。     

Cloned calves produced by nuclear transfer from cultured cumulus cells

Short-term cultured cumulus cell lines (1-5BCC) derived from 5 individual cows were used in nuclear transfer (NT) and 1188 enucleated bovine oocytes matured in vitro were used as nuclear recipients. A total of 931 (78.4%) cloned embryos were reconstructed, of which 763 (82%) cleaved, 627 (67.3%) developed to 8-cell stage, and 275 (29.5%) reached blastocyst stage. The average cell number of blastocysts was 124±24.5 (n=20). In this study, the effects of donor cell sources, serum starvation of donor cells, time interval from fusion to activation (IFA) were also tested on cloning efficiency. These results showed that blastocyst rates of embryos reconstructed from 5 different individuals cells were significantly different among them (14.1%, 45.2%, 27.3%, 34.3%, vs 1.5%, P<0.05); that serum starvation of donor cells had no effect on blastocyst development rate of NT embryos (47.1% vs 44.4%, P>0.05); and that blastocyst rate (20.3%) of the group with fusion/activation interval of 2–3 h, was significantly lower than that of the 3–6 h groups (31.0%), while not significantly different among 3–4 h (P < 0.05), 4–5 h, and 5–6 h groups (P≥0.05). Sixty-three thawed NT blastocysts were transferred to 31 recipient cows, of which 4 pregnancies were established and two cloned calves were given birth. These results indicate that serum starvation of cumulus cells is not a key factor for successful bovine cloning, while IFA treatment and sources of donor cells have effects on cloning efficiency.     

Cloned calves produced by nuclear transfer from cultured cumulus cells

Short-term cultured cumulus cell lines (1-5BCC) derived from 5 individual cows were used in nuclear transfer (NT) and 1188 enucleated bovine oocytes matured in vitro were used as nuclear recipients. A total of 931 (78.4%) cloned embryos were reconstructed, of which 763 (82%) cleaved, 627 (67.3%) developed to 8-cell stage, and 275 (29.5%) reached blastocyst stage. The average cell number of blastocysts was 124±24.5 (n=20). In this study, the effects of donor cell sources, serum starvation of donor cells, time interval from fusion to activation (IFA) were also tested on cloning efficiency. These results showed that blastocyst rates of embryos reconstructed from 5 different individuals cells were significantly different among them (14.1%, 45.2%, 27.3%, 34.3%, vs 1.5%, P<0.05); that serum starvation of donor cells had no effect on blastocyst development rate of NT embryos (47.1% vs 44.4%, P>0.05); and that blastocyst rate (20.3%) of the group with fusion/activation interval of 2-3 h, was significantly lower